BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15905564)

  • 1. IL-4-transfected tumor cell vaccines activate tumor-infiltrating dendritic cells and promote type-1 immunity.
    Eguchi J; Kuwashima N; Hatano M; Nishimura F; Dusak JE; Storkus WJ; Okada H
    J Immunol; 2005 Jun; 174(11):7194-201. PubMed ID: 15905564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-21 activates both innate and adaptive immunity to generate potent antitumor responses that require perforin but are independent of IFN-gamma.
    Ma HL; Whitters MJ; Konz RF; Senices M; Young DA; Grusby MJ; Collins M; Dunussi-Joannopoulos K
    J Immunol; 2003 Jul; 171(2):608-15. PubMed ID: 12847225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crucial role of IL-4/STAT6 in T cell-mediated hepatitis: up-regulating eotaxins and IL-5 and recruiting leukocytes.
    Jaruga B; Hong F; Sun R; Radaeva S; Gao B
    J Immunol; 2003 Sep; 171(6):3233-44. PubMed ID: 12960353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-21 induces tumor rejection by specific CTL and IFN-gamma-dependent CXC chemokines in syngeneic mice.
    Di Carlo E; Comes A; Orengo AM; Rosso O; Meazza R; Musiani P; Colombo MP; Ferrini S
    J Immunol; 2004 Feb; 172(3):1540-7. PubMed ID: 14734732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-12p40-overexpressing immature dendritic cells induce T cell hyporesponsiveness in vitro but accelerate allograft rejection in vivo: role of NK cell activation and interferon-gamma production.
    Sun W; He X; Guo Z; Wang Q; Li X; Rayner J; Zhang L; Wang J; Cao X
    Immunol Lett; 2004 Jul; 94(3):191-9. PubMed ID: 15275966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paracrine release of IL-12 stimulates IFN-gamma production and dramatically enhances the antigen-specific T cell response after vaccination with a novel peptide-based cancer vaccine.
    Salem ML; Kadima AN; Zhou Y; Nguyen CL; Rubinstein MP; Demcheva M; Vournakis JN; Cole DJ; Gillanders WE
    J Immunol; 2004 May; 172(9):5159-67. PubMed ID: 15100252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of T-cell subsets and natural killer (NK) cells in the growth suppression of murine fibrosarcoma cells transfected with interleukin-12 (IL-12) genes.
    Schmitt M; Ikeda H; Nagata Y; Gu X; Wang L; Kuribayashi K; Shiku H
    Int J Cancer; 1997 Jul; 72(3):505-11. PubMed ID: 9247296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of antitumor immunity by tumor cells transduced with a retroviral vector carrying the interleukin-2 and interferon-gamma cDNAs.
    Rosenthal FM; Cronin K; Bannerji R; Golde DW; Gansbacher B
    Blood; 1994 Mar; 83(5):1289-98. PubMed ID: 8118032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of a mammary adenocarcinoma in STAT6-/- mice is dependent on the presence of STAT6-reactive T cells.
    Jensen SM; Meijer SL; Kurt RA; Urba WJ; Hu HM; Fox BA
    J Immunol; 2003 Feb; 170(4):2014-21. PubMed ID: 12574371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutting edge: spontaneous rejection of poorly immunogenic P1.HTR tumors by Stat6-deficient mice.
    Kacha AK; Fallarino F; Markiewicz MA; Gajewski TF
    J Immunol; 2000 Dec; 165(11):6024-8. PubMed ID: 11086033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-4 and IL-12 regulate proteoglycan-induced arthritis through Stat-dependent mechanisms.
    Finnegan A; Grusby MJ; Kaplan CD; O'Neill SK; Eibel H; Koreny T; Czipri M; Mikecz K; Zhang J
    J Immunol; 2002 Sep; 169(6):3345-52. PubMed ID: 12218156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance.
    Zhou P; Szot GL; Guo Z; Kim O; He G; Wang J; Grusby MJ; Newell KA; Thistlethwaite JR; Bluestone JA; Alegre ML
    J Immunol; 2000 Nov; 165(10):5580-7. PubMed ID: 11067913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducible expression of Stat4 in dendritic cells and macrophages and its critical role in innate and adaptive immune responses.
    Fukao T; Frucht DM; Yap G; Gadina M; O'Shea JJ; Koyasu S
    J Immunol; 2001 Apr; 166(7):4446-55. PubMed ID: 11254700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects.
    Osaki T; PĂ©ron JM; Cai Q; Okamura H; Robbins PD; Kurimoto M; Lotze MT; Tahara H
    J Immunol; 1998 Feb; 160(4):1742-9. PubMed ID: 9469432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of dendritic cells engineered to secrete IFN-alpha into central nervous system tumors enhances the efficacy of peripheral tumor cell vaccines: dependence on apoptotic pathways.
    Kuwashima N; Nishimura F; Eguchi J; Sato H; Hatano M; Tsugawa T; Sakaida T; Dusak JE; Fellows-Mayle WK; Papworth GD; Watkins SC; Gambotto A; Pollack IF; Storkus WJ; Okada H
    J Immunol; 2005 Aug; 175(4):2730-40. PubMed ID: 16081851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating levels of IL-10 are critically related to growth and rejection patterns of murine mastocytoma cells.
    Grohmann U; Silla S; Belladonna ML; Bianchi R; Orabona C; Puccetti P; Fioretti MC
    Cell Immunol; 1997 Nov; 181(2):109-19. PubMed ID: 9398398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominance of IL-12 over IL-4 in gamma delta T cell differentiation leads to default production of IFN-gamma: failure to down-regulate IL-12 receptor beta 2-chain expression.
    Yin Z; Zhang DH; Welte T; Bahtiyar G; Jung S; Liu L; Fu XY; Ray A; Craft J
    J Immunol; 2000 Mar; 164(6):3056-64. PubMed ID: 10706694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-specific Tc1, but not Tc2, cells deliver protective antitumor immunity.
    Kemp RA; Ronchese F
    J Immunol; 2001 Dec; 167(11):6497-502. PubMed ID: 11714817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor effects of a tumor cell vaccine expressing a membrane-bound form of the IL-12 p35 subunit.
    Lim HY; Ju HY; Chung HY; Kim YS
    Cancer Biol Ther; 2010 Aug; 10(4):336-43. PubMed ID: 20534980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.